Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00644683

Completed

A Pilot Observational Study to Assess Changes in Biochemical Parameters of Ovarian Reserve With Chemotherapy

Breast Cancer
NCT00517088

Completed

Level of Physical Activities in Patients Before and After Breast Cancer Treatment (PABC)

Breast Cancer
NCT00003050

Completed

Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer

Breast Cancer
NCT01459003

Completed

Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer (BEAUTY)

Breast Cancer
NCT01127763

Completed

RAD001 Plus Carboplatin in Breast Cancer Patients

Breast Cancer
NCT01513356

Completed

Pharmacodynamic Study of BKM120 in Breast Cancer

Breast Cancer
NCT00600249

Completed

Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.

Breast Cancer
NCT01153126

Completed

Moderating the Negative Impact of Abnormal Screening Mammograms

Breast Cancer
NCT02059876

Unknown

Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast Cancer

Breast Cancer
NCT00068614

Completed

HER-2 Protein Vaccine in Treating Women With Breast Cancer

Breast Cancer
NCT00312208

Completed

Docetaxel in Breast Cancer

Breast Cancer
NCT00003678

Unknown

Tamoxifen in Treating Women With Breast Cancer

Breast Cancer
NCT00027989

Unknown

Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer

Breast Cancer
NCT00010140

Unknown

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Cancer
NCT00005581

Unknown

Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer

Breast Cancer
NCT01866202

Unknown

Study of Circulating and Tumor Biomarkers in Breast Cancer Patients

Breast Cancer
NCT01866631

Unknown

Using National University Cancer Institute of Singapore (NCIS) Registry to Measure Time Trends in Quality of Care for Breast Cancer Patients in a National Cancer Centre

Breast Cancer
NCT01991340

Completed

H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast Cancer

Breast Cancer
NCT00529334

Withdrawn

A Pilot Study of CyberKnife Radiosurgery Delivered to the Partial Breast (CK-PBI)

Breast Cancer
NCT01849328

Unknown

Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air

Breast Cancer
NCT00002579

Completed

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

Breast Cancer
NCT00003012

Completed

Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer

Breast Cancer
NCT00002755

Completed

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Breast Cancer
NCT00002581

Completed

Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer

Breast Cancer
NCT00002580

Completed

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer

Breast Cancer
NCT00657345

Completed

IRS Proteins and Trastuzumab Resistance

Breast Cancer
NCT00290732

Completed

Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer

Breast Cancer
NCT01230671

Completed

The Physical and Psychological Benefits of Yoga and Breast Cancer

Breast Cancer
NCT01622361

Unknown

Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer (NEST)

Breast Cancer
NCT00938652

Completed

A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

Breast Cancer
NCT01038804

Completed

A Study of YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

Breast Cancer
NCT00104702

Completed

Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer (GERICO03)

Breast Cancer
NCT01554943

Completed

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Breast Cancer
NCT00539227

Completed

A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy

Breast Cancer
NCT00691509

Unknown

Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer

Breast Cancer
NCT00284180

Completed

Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer

Breast Cancer | Breast Neoplasms
NCT00006030

Unknown

Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

Breast Cancer
NCT00629278

Unknown

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Breast Cancer
NCT00002460

Unknown

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Breast Cancer
NCT00002696

Suspended

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Breast Cancer
NCT00320541

Completed

A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer

Breast Cancer
NCT00041353

Withdrawn

Comparison of Biomarkers Based on Fine-Needle Aspiration in Women at Increased or Normal Risk of Breast Cancer

Breast Cancer
NCT01185145

Active, not recruiting

Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy (APBI)

Breast Cancer
NCT01666171

Unknown

Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32

Breast Cancer
NCT01614184

Withdrawn

Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer

Breast Cancer
NCT00031850

Completed

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Breast Cancer
NCT00002967

Completed

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

Breast Cancer
NCT00674791

Completed

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Breast Cancer
NCT00589238

Terminated

Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery

Breast Cancer
NCT00897091

Completed

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations